Jiangsu Apon Medical Technology Co Ltd Class A (300753) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.004x

Based on the latest financial reports, Jiangsu Apon Medical Technology Co Ltd Class A (300753) has a cash flow conversion efficiency ratio of -0.004x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-2.69 Million ≈ $-394.26K USD) by net assets (CN¥686.08 Million ≈ $100.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Jiangsu Apon Medical Technology Co Ltd C defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Jiangsu Apon Medical Technology Co Ltd Class A - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Jiangsu Apon Medical Technology Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jiangsu Apon Medical Technology Co Ltd Class A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangsu Apon Medical Technology Co Ltd Class A ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Puma Biotechnology Inc
NASDAQ:PBYI
0.111x
Shanghai Hi-Road Food Technology Co. Ltd.
SHE:300915
-0.003x
Taiwan Steel Union Co Ltd
TW:6581
0.035x
Hyundai Motor Securities Co. Ltd.
KO:001500
-0.045x
Orthofix Medical Inc
NASDAQ:OFIX
-0.040x
Wuhu Fuchun Dye and Weave Co.Ltd.
SHG:605189
0.362x
Silvaco Group, Inc. Common Stock
NASDAQ:SVCO
-0.144x
Wei Long Grape Wine Co Ltd
SHG:603779
-0.049x

Annual Cash Flow Conversion Efficiency for Jiangsu Apon Medical Technology Co Ltd Class A (2014–2024)

The table below shows the annual cash flow conversion efficiency of Jiangsu Apon Medical Technology Co Ltd Class A from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see Jiangsu Apon Medical Technology Co Ltd C market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥707.86 Million
≈ $103.58 Million
CN¥15.68 Million
≈ $2.29 Million
0.022x +166.18%
2023-12-31 CN¥697.20 Million
≈ $102.02 Million
CN¥-23.34 Million
≈ $-3.41 Million
-0.033x +6.59%
2022-12-31 CN¥686.36 Million
≈ $100.44 Million
CN¥-24.59 Million
≈ $-3.60 Million
-0.036x -252.95%
2021-12-31 CN¥780.52 Million
≈ $114.21 Million
CN¥18.29 Million
≈ $2.68 Million
0.023x -79.20%
2020-12-31 CN¥739.84 Million
≈ $108.26 Million
CN¥83.34 Million
≈ $12.20 Million
0.113x -2.02%
2019-12-31 CN¥674.88 Million
≈ $98.76 Million
CN¥77.59 Million
≈ $11.35 Million
0.115x -9.73%
2018-12-31 CN¥613.39 Million
≈ $89.76 Million
CN¥78.13 Million
≈ $11.43 Million
0.127x -46.95%
2017-12-31 CN¥279.38 Million
≈ $40.88 Million
CN¥67.08 Million
≈ $9.82 Million
0.240x -9.59%
2016-12-31 CN¥229.59 Million
≈ $33.60 Million
CN¥60.97 Million
≈ $8.92 Million
0.266x +1.41%
2015-12-31 CN¥145.40 Million
≈ $21.28 Million
CN¥38.08 Million
≈ $5.57 Million
0.262x -36.37%
2014-12-31 CN¥81.37 Million
≈ $11.91 Million
CN¥33.49 Million
≈ $4.90 Million
0.412x --

About Jiangsu Apon Medical Technology Co Ltd Class A

SHE:300753 China Medical Instruments & Supplies
Market Cap
$381.99 Million
CN¥2.61 Billion CNY
Market Cap Rank
#13799 Global
#4131 in China
Share Price
CN¥20.71
Change (1 day)
-0.58%
52-Week Range
CN¥20.12 - CN¥43.19
All Time High
CN¥43.19
About

Jiangsu Apon Medical Technology Co., Ltd. engages in the research and development, production, and sale of medical devices in China. The company's principal products include microcomputer injection pumps, disposable injection pumps, wireless analgesia management systems, and pulse oximeters, as well as medical devices, such as sensors in the field of pain management and nasal care sprayers. Jiang… Read more